Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia

ClinicalTrials.gov ID: NCT01244763

Public ClinicalTrials.gov record NCT01244763. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 2:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Open-Label, Dose Titration, Efficacy and Safety Study of FG-4592 (Roxadustat) in Non-Dialysis Chronic Kidney Disease Patients With Anemia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of this study is to evaluate efficacy and safety of roxadustat in the correction of anemia in participants with non-dialysis chronic kidney disease.

Study identification

NCT ID
NCT01244763
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Kyntra Bio
Industry
Enrollment
145 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 28, 2010
Primary completion
Jun 12, 2012
Completion
Jun 12, 2012
Last update posted
Feb 9, 2022

2010 – 2012

United States locations

U.S. sites
35
U.S. states
19
U.S. cities
35
Facility City State ZIP Site status
Not listed Mobile Alabama
Not listed Pine Bluff Arkansas
Not listed Azusa California
Not listed Chula Vista California
Not listed Downey California
Not listed Northridge California
Not listed Paramount California
Not listed Riverside California
Not listed Whittier California
Not listed Yuba City California
Not listed Fort Lauderdale Florida
Not listed Lauderdale Lakes Florida
Not listed Pembroke Pines Florida
Not listed Tampa Florida
Not listed Augusta Georgia
Not listed Meridian Idaho
Not listed Wichita Kansas
Not listed Baton Rouge Louisiana
Not listed Shreveport Louisiana
Not listed Bethesda Maryland
Not listed Detroit Michigan
Not listed Lincoln Nebraska
Not listed Mount Laurel New Jersey
Not listed Mineola New York
Not listed New York New York
Not listed Asheville North Carolina
Not listed Raleigh North Carolina
Not listed Canton Ohio
Not listed Orangeburg South Carolina
Not listed Knoxville Tennessee
Not listed Arlington Texas
Not listed Fort Worth Texas
Not listed Houston Texas
Not listed San Antonio Texas
Not listed Fairfax Virginia

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01244763, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 9, 2022 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01244763 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →